BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20508188)

  • 1. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke.
    Kamel H; Hegde M; Johnson DR; Gage BF; Johnston SC
    Stroke; 2010 Jul; 41(7):1514-20. PubMed ID: 20508188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter by Wachter et al regarding article "Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke".
    Wachter R; Stahrenberg R; Gröschel K
    Stroke; 2011 Mar; 42(3):e36; author reply e37. PubMed ID: 21273570
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke.
    Yong JH; Thavorn K; Hoch JS; Mamdani M; Thorpe KE; Dorian P; Sharma M; Laupacis A; Gladstone DJ;
    Stroke; 2016 Sep; 47(9):2380-5. PubMed ID: 27470989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Kamel H; Johnston SC; Easton JD; Kim AS
    Stroke; 2012 Mar; 43(3):881-3. PubMed ID: 22308255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke.
    Levin LÅ; Husberg M; Sobocinski PD; Kull VF; Friberg L; Rosenqvist M; Davidson T
    Europace; 2015 Feb; 17(2):207-14. PubMed ID: 25349228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J; Delaitre O; Hammès F; de Pouvourville G
    Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous monitoring versus HOLTER ECG for detection of atrial fibrillation in patients with stroke.
    Gumbinger C; Krumsdorf U; Veltkamp R; Hacke W; Ringleb P
    Eur J Neurol; 2012 Feb; 19(2):253-7. PubMed ID: 21895885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study.
    Grond M; Jauss M; Hamann G; Stark E; Veltkamp R; Nabavi D; Horn M; Weimar C; Köhrmann M; Wachter R; Rosin L; Kirchhof P
    Stroke; 2013 Dec; 44(12):3357-64. PubMed ID: 24130137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review.
    Liao J; Khalid Z; Scallan C; Morillo C; O'Donnell M
    Stroke; 2007 Nov; 38(11):2935-40. PubMed ID: 17901394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective.
    Maervoet J; Bossers N; Borge RP; Hilpert ST; van Engen A; Smala A
    J Med Econ; 2019 Nov; 22(11):1221-1234. PubMed ID: 31480905
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia.
    Mayer F; Stahrenberg R; Gröschel K; Mostardt S; Biermann J; Edelmann F; Liman J; Wasem J; Goehler A; Wachter R; Neumann A
    Clin Res Cardiol; 2013 Dec; 102(12):875-84. PubMed ID: 23904073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia.
    Ademi Z; Pasupathi K; Liew D
    Eur J Prev Cardiol; 2015 Mar; 22(3):344-53. PubMed ID: 24281250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.
    O'Brien CL; Gage BF
    JAMA; 2005 Feb; 293(6):699-706. PubMed ID: 15701911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of extended electrocardiogram monitoring for atrial fibrillation in patients with cryptogenic stroke.
    Chew DS; Rennert-May E; Quinn FR; Buck B; Hill MD; Spackman E; Manns BJ; Exner DV
    Int J Stroke; 2021 Oct; 16(7):809-817. PubMed ID: 33232196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient cardiac telemetry detects a high rate of atrial fibrillation in cryptogenic stroke.
    Miller DJ; Khan MA; Schultz LR; Simpson JR; Katramados AM; Russman AN; Mitsias PD
    J Neurol Sci; 2013 Jan; 324(1-2):57-61. PubMed ID: 23102659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke.
    Diamantopoulos A; Sawyer LM; Lip GY; Witte KK; Reynolds MR; Fauchier L; Thijs V; Brown B; Quiroz Angulo ME; Diener HC
    Int J Stroke; 2016 Apr; 11(3):302-12. PubMed ID: 26763916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection.
    Edwards JD; Kapral MK; Fang J; Saposnik G; Gladstone DJ;
    Stroke; 2016 Aug; 47(8):1982-9. PubMed ID: 27406109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and paroxysmal atrial fibrillation detection in patients with acute ischemic stroke.
    Sutamnartpong P; Dharmasaroja PA; Ratanakorn D; Arunakul I
    J Stroke Cerebrovasc Dis; 2014; 23(5):1138-41. PubMed ID: 24189453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal timing and duration of continuous electrocardiographic monitoring for detecting atrial fibrillation in stroke patients.
    Suissa L; Lachaud S; Mahagne MH
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):991-5. PubMed ID: 22349706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.